-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Cyteir Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2020 to Q3 2023.
- Cyteir Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2023 was $1.64M, a 130% increase year-over-year.
- Cyteir Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2023 was $5.04M, a 462% increase year-over-year.
- Cyteir Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $2.11M, a 1486% increase from 2021.
- Cyteir Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $133K, a 10.8% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)